As for the development of MA in nAMD eyes under anti-VEGF therapy, IRF in foveal center at baseline was identified as a risk factor for MA incidence in the Comparison of Age-Related Macular Degeneration Treatments Trials (12). Here, VEGFA is linked to age-related macular degeneration.